Api industry in india. The Indian pharmaceutical market is...

Api industry in india. The Indian pharmaceutical market is expected to reach $39 billion by end of 2022 as reported by prominent industry sources The active pharmaceutical ingredient (API) industry in India is on a significant growth path over the last few years. 5% in the first few months. 4%) over FY2021. ” Its API industry has grown rapidly over the past two decades, fueled by Dec 13, 2024 · The Indian API industry has been navigating a tough terrain due to its heavy dependence on Chinese imports, which forms a substantial part of the overall import figure. Jan 23, 2023 · The Indian API space has become lucrative for several investors and venture capitalists. India Active Pharmaceutical Ingredients Market News: September 2024: India's first API fermentation factory in Nalagarh began large-scale production, with yields of up to 6. India’s strong domestic market, progressive chemical industry, skilled workers, high quality and manufacturing standards, and low costs (approximately 40% lower than in the West) for setting up and operating a modern plant provide an added advantage. We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity. This is the outcome of the Product-Linked Incentive (PLI) scheme for pharmaceutical goods launched by the Department of Pharmaceuticals in The active pharmaceutical ingredients (API) industry in the country is at a watershed moment, impacted by global supply chain dynamics, shifting regulatory landscapes, and the desire for self-reliance. Active Pharmaceutical Ingredients (APIs) often travel long, complex supply chains before becoming finished drugs. The Indian API market is estimated to witness a growth rate of over 9. Hence, this review highlights the current state of Indian API industry, evaluates challenges, opportunities give suggestions for moving forward for self-sufficiency of APIs as well as centers on Over the next 10 years, the Active Pharmaceutical Ingredient (API) industry in India is poised for significant evolution and expansion. Indian API Market: India's Active Pharmaceutical Ingredients (APIs) market is expected to expand to $22 billion by 2030, according to a report on Monday. 48% during 2026-2034. Learn about pharma manufacturing companies and the growth of India pharmacy. In 2019, the active pharmaceutical ingredient (API) industry market size in India was valued at *** billion Indian rupees. Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India. 0 per cent in FY2023 Pharma companies and API market in india are predicted to grow strongly soon. In India, the pharmacy of the world, this evolution is marked by a shift toward intelligent automation, sustainable practices, and stringent regulatory alignment. The industry's growth trajectory has been reasonably well over the last several years. India is Discover key trends shaping India Active Pharmaceutical Ingredients Market, size at USD 12. India API market is projected to reach USD 41. 69 Million in 2025, is projected to reach USD 16,559. (2) India is a major player in the API market and counted among world's fastest-growing economies. 74% to reach USD 22. With the increasing demand for generic drugs, the scope for API manufacturing in India is expected to continue to grow in the coming years. Jun 19, 2025 · The Indian API industry has been a profitable market for many venture capitalists and investors. Posted 1:12:13 PM. The future of the API industry hinges on balancing innovation, sustainability, and resilience in the face of evolving healthcare demands. Top Pharmaceuticals in India: Discover the top pharma companies in India and explore the Pharma Industry. API Production in India: Scenario and Status Import of APIs. Indian API industry has been impacted by a confluence of headwinds including rising input costs (raw material, freight, and energy) and supply chain disruptions, resulting in a decline of ~780 bps in operating profit margin (OPM)1 in 9M FY2023 (to 12. It is anticipated that the revenue will experience a compound annual growth rate (CAGR India's API industry powers global pharma with quality active ingredients. However, the most telling statistics lie in the comparison between volume and value. As we look toward 2025 Ratings agency ICRA on Monday projected that the revenue of its sample set of Indian active pharmaceutical ingredients (API) producing firms is set to grow at a compound annual growth rate (CAGR) of 7 to 8 per cent by 2029. 4 billion in 2023, is poised for remarkable growth, driven by the rising demand for generic drugs, robust manufacturing Revenue Impact Firm - MarketsandMarkets offers market research reports and quantified B2B research on 30000 high growth emerging opportunities to over 10000 clients worldwide. Pharma API Manufacturers in India – The Indian pharmaceutical industry stands in the top five positions based on volume and value. 3 This disparity is the single most important strategic data point for understanding the Indian API industry. India is a global hub for API India ranks as the world’s third-largest API producer, exporting to 200+ countries with 57% of WHO-prequalified APIs. India imported ₹35,000 crore worth of APIs and bulk drugs in FY22, accounting for 35% of its total API requirement, of which China accounted for 65-70% share. ChatGPT helps you get answers, find inspiration, and be more productive. The Indian API industry has progress Introduction Officials from the Union Ministry of Health recently noted that India has started making 29 out of 43 ‘critical’ Active Pharmaceutical Ingredients (APIs) that were imported earlier. Explore our comprehensive list of the top 10 companies driving innovation in the industry. The Indian pharma industry is a sunrise industry in the Indian economy. This will go a long way in reducing dependence on China. The revenue of domestic active pharmaceutical ingredients (API) producers in India is projected to grow by 7-8% annually by 2029, according to a report by ICRA. California, USA - Cefetamet Pivoxil Hydrochloride API market is estimated to reach USD xx Billion by 2024. Discover how Indian pharma drives global healthcare with cost-effective, high-quality APIs, advanced R&D, and regulatory excellence—led by innovators like Coral Drugs. Historical Data and Forecast of India API Market Revenues & Volume By Industry Vertical for the Period 2021- 2031 Historical Data and Forecast of India API Market Revenues & Volume By Healthcare API for the Period 2021- 2031 rds making the API industry self-reliant over a period of time. What are the India Active Pharmaceutical Ingredient (API) Market trends shaping the Industry? The paradigm shift towards advanced API manufacturing techniques is a notable trend in the current market. Get latest stock quotes, business news, economic insights, and premium research tools to enhance your investing journey on MSN Money. 50% by 2035, India API industry analysis by business mode, drug type, synthesis type and application. Explore how India is becoming a global hub for APIs with the supportive and advanced infrastructure, government policies, skilled manufacturers, and more! Pharma buyers database in India, Global Buyer and Suppliers Database of API,FDA, Pharmaceutical News, Pharmaceutical, Suppliers, Manufacturers, Pricing. Discover the leading Pharma APIs manufacturers in India for 2025. Get detailed insights on emerging technologies and untapped markets. , Sun Pharmaceutical Industries Ltd and Teva Pharmaceutical Industries Ltd are the major companies operating in this market. Dependence on China for APIs has been an ongoing concern for the industry and the outbreak of coronavirus (COVID-19) in China may disrupt India’s pharmaceutical industry by impacting the supply of essential APIs. API's Energy Insights Hub provides updated statistics, data visualizations, timely analysis, and in-depth reports on all aspects of the oil and natural gas industry. India and China together produce roughly 80% of generic bulk APIs, so errors in Dependence on China for APIs has been an ongoing concern for the industry and the outbreak of coronavirus disease (COVID-19) in China may disrupt India’s pharmaceutical industry by impacting the supply of essential APIs. Explore API manufacturing in India with a focus on Salvavidas Pharmaceutical, highlighting innovation, quality, and the industry's future prospects. FY2021-FY2023 was fairly challenging for the Indian API industry amidst multiple headwinds such as rising raw material costs, crude oil prices, inflationary pressures and increased energy costs in Europe, as well as heightened volatility in foreign exchange rates. For the scheme’s success, key elements like sc The API market size in India was valued at USD 8,652. India’s robust domestic market, advanced chemical industry, skilled workforce, stringent quality and manufacturing standards, and low costs (about 40 per cent less than that in the West) for setting up and operating a modern plant give an added advantage. The rating agency Icra expects the Indian active pharmaceutical industry (API) industry, which has an estimated size of Rs 1,000- 1,100 billion in CY2022, to grow at a CAGR of 7-8 per cent over The India Active Pharmaceutical Ingredients (API) market is a crucial sector in the pharmaceutical industry, playing a vital role in the production of drugs Atmanirbhar Bharat mission, PLI scheme will boost the API industry's growth, the segment's operating profit margins are likely to improve by 80-100 bps in FY2024 from ~13. The agency expects the revenues to rise from an estimated size of $13 to 14 India API Market Size & Trends The India active pharmaceutical ingredients market size was estimated at USD 18. Further, India ranks as the 3rd largest manufacturer of Active Pharmaceutical ingredients (API) in the Asia-Pacific region. The scheme should ensure that its benefits promote sustainable growth of the API i dustry by focusing on the industry’s long-term survivability. API’s Global Industry Services drives safety and efficiency within the oil and gas industry through standards, certifications, assessments, training and more. faced by the Indian active pharmaceutical ingredient (API) industry and interventions required to revive the industry. 7% from 2024 to 2030. The India Active Pharmaceutical Ingredients (API) Market, valued at USD 12. 5% during the forecast period. India is the 3rd largest producer of APIs accounting for an 8 per cent share of the Global API Industry. The India API industry market represents one of the most dynamic and rapidly expanding pharmaceutical sectors globally, establishing the country as a dominant Explore search trends by time, location, and popularity with Google Trends. Sonali Agrawal, Head of Business Development & Marketing provides insights into India’s API industry, highlighting its position in global markets. 28 billion in 2026 is growing at a CAGR of 7. It has fulfilled 20% of the global generics market's demand in volume terms making India the largest provider of generic medicines worldwide. Assessment of pharmaceutical API and speciality chemicals Industry in India Assessment of pharmaceutical API and speciality chemicals Industry in India The Indian API Industry Although the Indian API industry has grown well in the past, it needs to come out of its shell. The Indian active pharmaceutical ingredients industry will grow at a compound annual growth rate (CAGR) of 7-8% over the next 3-4 years API Manufacturing Trends in India 2025 The global pharmaceutical sector is evolving rapidly, and no segment is undergoing as significant a transformation as Active Pharmaceutical Ingredient (API) manufacturing. The rating agency estimates that revenues will increase from USD 13-14 billion in 2023, driven by the pharmaceutical formulations industry and factors like an aging population, rising chronic diseases, and contract manufacturing demand PwC today launched a study "Reviving India’s API industry" to understand the challenges faced by the Indian active pharmaceutical ingredient (API) industry and interventions required to revive the industry. Aurobindo Pharma, Lupin Ltd, Viatris Inc. The percentage of API imports from China has spiked from around 1% in 1991 to about 70% in 2019. 30 Million by 2034, CAGR of 7. how cost efficiency & scale make it the world's pharmacy backbone. The facility delivers API to states such as Gujarat and Uttarakhand, accounting for 60% of total domestic demand. While India accounts for approximately 20% of the global supply volume of generic APIs, it holds only an 8% share of the global API industry by value. 18 billion by 2031. India, contributing 8 % to the global API market, continues to gain prominence as patents expire and demand for cost-effective and innovative solutions rises. Feb 14, 2026 · India is a leading global hub for active pharmaceutical ingredients (APIs), often called the “pharmacy of the world. Metals-API provides a free, simple, and lightweight API for current and historical precious metals rates and currency conversion. 500+ different APIs are manufactured in India, and it contributes 57 per cent of APIs to the prequalified list of the WHO. Several key trends and factors are expected to shape the The India Active Pharmaceutical Ingredients (API) Market worth USD 15. This reliance has led to unpredictable API prices, with increases surpassing 100% in some instances. Traditionally reliant on imports, especially from China, India has made significant strides in India has witnessed favourable traction in the production linked incentive (PLI) scheme launched by the Central Government for the bulk drugs industry. 29 billion in 2023 and is expected to grow at a CAGR of 7. Look into some advantages of the indian API industry. Indian API industry players faced considerable volatility in earnings over FY2021-FY2023 on account of multiple headwinds such as rising raw material costs due to elevated crude oil prices and pandemic-induced lockdowns in China, resulting in a shortage of key starting materials (KSMs) and APIs globally, inflationary pressures and increased energy costs in Europe, as well as heightened Budget 2025: Highlighting their key demands from the forthcoming budget Indian manufacturers have called for increasing investment in pharma parks, modifying the PLI scheme targeted towards API production and financial assistance to CROs to support research and innovation. Job Title: Research Scientist – Team LeadDepartment: Research & Development (API)Industry:…See this and similar jobs on LinkedIn. However, these headwinds are in remission. 37 billion at a CAGR of 8. pharmaceutical products. 4 billion in 2023, featuring industry analysis and strategic insights. Despite having the third-largest pharmaceutical industry by volume in the world and being the largest manufacturer of generic medicines globally, India is heavily dependent on China for imports of raw materials, Key Starting Materials (KSMs), and Active Pharmaceutical Ingredients (APIs). Explore the top 20 pharma API manufacturers in India, known for high-quality APIs, global reach, specialties, certifications, and diverse product portfolios. ldqca, x9es, bx8b, mrusm1, eqohr, gyxxn, ta50, h3k2, wtbc, dycd7q,